Explore more publications!
Louisiana Health Daily
Got News to Share?

Louisiana Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Health Daily.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 7, 2025

T-knife Therapeutics Presents Preclinical Data Highlighting the Transformative Potential of the MyT™ Platform to Discover and Develop Next-Generation TCR Therapies to Treat Solid Tumors at the European Society of Gene & Cell Therapy (ESGCT) 2025 Annual…
October 7, 2025

T-knife Therapeutics Presents Preclinical Data Highlighting the Transformative Potential of the MyT™ Platform to Discover and Develop Next-Generation TCR Therapies to Treat Solid Tumors at the European Society of Gene & Cell Therapy (ESGCT) 2025 Annual…

Indeterminate GlobeNewswire
Humacyte Announces Pricing of $60.0 Million Oversubscribed Registered Direct Offering
October 7, 2025

Humacyte Announces Pricing of $60.0 Million Oversubscribed Registered Direct Offering

Indeterminate GlobeNewswire
MAIA Biotechnology to Initiate Digital Asset Treasury Strategy Focused on Top-Tier Crypto Assets
October 7, 2025

MAIA Biotechnology to Initiate Digital Asset Treasury Strategy Focused on Top-Tier Crypto Assets

Indeterminate GlobeNewswire
Propanc Reports End of Fiscal Year Highlights and Outlines Therapeutic Development & $100M+ Digital Asset Treasury Strategy
October 7, 2025

Propanc Reports End of Fiscal Year Highlights and Outlines Therapeutic Development & $100M+ Digital Asset Treasury Strategy

Indeterminate GlobeNewswire
Aligos Therapeutics Announces Eight Abstracts Accepted at The Liver Meeting® 2025
October 7, 2025

Aligos Therapeutics Announces Eight Abstracts Accepted at The Liver Meeting® 2025

Indeterminate GlobeNewswire
Clover Health to Report Third Quarter 2025 Financial Results on November 4, 2025
October 7, 2025

Clover Health to Report Third Quarter 2025 Financial Results on November 4, 2025

Indeterminate GlobeNewswire
GATC Health Announces Launch of Derisq: The Definitive AI Report for Predictive Risk Assessment of Drug Candidates at Fierce Biotech Week 2025
October 7, 2025

GATC Health Announces Launch of Derisq: The Definitive AI Report for Predictive Risk Assessment of Drug Candidates at Fierce Biotech Week 2025

Indeterminate GlobeNewswire
Prenetics Completes $72 Million ACT Exit, Bolsters Cash and Bitcoin Treasury to Accelerate IM8’s Path to $100 Million ARR
October 7, 2025

Prenetics Completes $72 Million ACT Exit, Bolsters Cash and Bitcoin Treasury to Accelerate IM8’s Path to $100 Million ARR

Indeterminate GlobeNewswire
Cellectar Biosciences, Inc. Enters Into Agreements to Raise $5.8 Million
October 7, 2025

Cellectar Biosciences, Inc. Enters Into Agreements to Raise $5.8 Million

Indeterminate GlobeNewswire
BBG Advanced Therapies and CELLforCURE Partner to Provide Transatlantic Manufacturing Solutions for Advanced Therapy Medicinal Products (ATMPs)
October 7, 2025

BBG Advanced Therapies and CELLforCURE Partner to Provide Transatlantic Manufacturing Solutions for Advanced Therapy Medicinal Products (ATMPs)

Indeterminate GlobeNewswire
CHESS Health Launches TouchPoint to Enable Multi-Channel Patient Engagement
October 7, 2025

CHESS Health Launches TouchPoint to Enable Multi-Channel Patient Engagement

Indeterminate GlobeNewswire
Profusa Invests Additional $1 Million in Digital Treasury Assets
October 7, 2025

Profusa Invests Additional $1 Million in Digital Treasury Assets

Indeterminate GlobeNewswire
Galectin Therapeutics to Present at the American Association for the Study of Liver Disease (AASLD) Liver Meeting 2025
October 7, 2025

Galectin Therapeutics to Present at the American Association for the Study of Liver Disease (AASLD) Liver Meeting 2025

Indeterminate GlobeNewswire
Bionano to Participate in the H.C. Wainwright @ Home Event
October 7, 2025

Bionano to Participate in the H.C. Wainwright @ Home Event

Indeterminate GlobeNewswire
Prime Medicine to Participate in Upcoming Investor Conferences
October 7, 2025

Prime Medicine to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Corbus Pharmaceuticals to Participate in the Upcoming Piper Sandler Virtual Oncology Symposium
October 7, 2025

Corbus Pharmaceuticals to Participate in the Upcoming Piper Sandler Virtual Oncology Symposium

Indeterminate GlobeNewswire
Kestra Appoints Timothy Moran as Chief Business Officer, Strengthening Leadership Team for Next Stage of Growth
October 7, 2025

Kestra Appoints Timothy Moran as Chief Business Officer, Strengthening Leadership Team for Next Stage of Growth

Indeterminate GlobeNewswire
TerrAscend to Host Third Quarter 2025 Earnings Conference Call
October 7, 2025

TerrAscend to Host Third Quarter 2025 Earnings Conference Call

Indeterminate GlobeNewswire
Arbutus Announces Four Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2025
October 7, 2025

Arbutus Announces Four Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2025

Indeterminate GlobeNewswire
Bluejay Therapeutics Announces Data Presentations in Chronic Hepatitis D (CHD) and Chronic Hepatitis B (CHB) at Upcoming American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2025
October 7, 2025

Bluejay Therapeutics Announces Data Presentations in Chronic Hepatitis D (CHD) and Chronic Hepatitis B (CHB) at Upcoming American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2025

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions